Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.

Qian L, Liu B, Zhang R, Zhang W, Wang S, Wu Y, Zhang T, Zhuang G, Jin D, Wang Q, Chen H

Open source

DOI
10.1038/s41388-026-03975-7
Published
2026 Sep 16
Container
Oncogene
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41388-026-03975-7,
  title = {Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.},
  author = {Qian L and Liu B and Zhang R and Zhang W and Wang S and Wu Y and Zhang T and Zhuang G and Jin D and Wang Q and Chen H},
  year = {2026},
  journal = {Oncogene},
  doi = {10.1038/s41388-026-03975-7},
  url = {https://doi.org/10.1038/s41388-026-03975-7}
}

RIS

TY  - JOUR
TI  - Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.
AU  - Qian L
AU  - Liu B
AU  - Zhang R
AU  - Zhang W
AU  - Wang S
AU  - Wu Y
AU  - Zhang T
AU  - Zhuang G
AU  - Jin D
AU  - Wang Q
AU  - Chen H
PY  - 2026
JO  - Oncogene
DO  - 10.1038/s41388-026-03975-7
UR  - https://doi.org/10.1038/s41388-026-03975-7
ER  - 

APA

L, Q., B, L., R, Z., W, Z., S, W., Y, W., T, Z., G, Z., D, J., Q, W., & H, C. (2026). Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.. Oncogene. https://doi.org/10.1038/s41388-026-03975-7

Source records